- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
Alexion Pharmaceuticals Inc. (ALXN)
Index:
- Closing Price Chg: $0.00
- 52 Week High: $0.00
- 52 Week Low: $0.00
- Currency: US Dollars
- Shares Issued: 219.50m
- Volume: 0
- RiskGrade: 193
Latest ShareCast News
AstraZeneca's Alexion acquisition cleared by European Commission
By Michele Maatouk
Date: Tuesday 06 Jul 2021
(Sharecast News) - AstraZeneca said on Tuesday that its $39bn proposed acquisition of US drug developer Alexion has been cleared by the European Commission.
UK's CMA to probe $39bn AstraZeneca-Alexion deal
By Frank Prenesti
Date: Tuesday 25 May 2021
(Sharecast News) - Britain's Competition and Markets Authority (CMA) said it is looking into AstraZeneca's $39bn acquisition of America's Alexion Pharmaceuticals over concerns the deal could harm competition in the UK.
S&P places AstraZeneca's debt on Credit Watch Positive on proposed purchase of Alexion
By Alexander Bueso
Date: Wednesday 16 Dec 2020
(Sharecast News) - Standard&Poor's placed its rating on AstraZeneca's long-term corporate debt on so-called Credit Watch Positive following news of its intended purchase of US rare disease specialist Alexion.
ALXN Market Data
| Currency | US Dollars |
| Share Price | $ 0.00 |
| Closing Price Change | $ 0.00 |
| % Change | 0.00 % |
| 52 Week High | $0.00 |
| 52 Week Low | $0.00 |
| Volume | 0 |
| Shares Issued | 219.50m |
| RiskGrade | 193 |
You are here: research
10 Lower Thames St,
London EC3R 6EN